Fourteen new thiazolyl hydrazone derivatives were synthesized and evaluated for their anticandidal activity using a broth microdilution assay. Among the synthesized compounds, 2-[2-((5-(4-chloro-2-nitrophenyl)furan-2-yl)methylene)hydrazinyl]-4-(4-fluorophenyl)thiazole and 2-[2-((5-(4-chloro-2-nitrophenyl)furan-2-yl)methylene) hydrazinyl]-4-(4-methoxyphenyl)thiazole were found to be the most effective antifungal compounds against Candida utilis, with a MIC value of 250 µg/mL, when compared with fluconazole (MIC = 2 µg/mL). Additionally, the synthesized compounds were evaluated for their in vitro cytotoxic effects on the MCF-7 and NIH/3T3 cell lines. As a result, 2-[2-((5-(4-chloro-2-nitrophenyl)furan-2-yl)methylene)hydrazinyl]-4-(4-chlorophenyl)thiazole was identified as the most promising anticancer compound against MCF-7 cancer cells due to its inhibitory effects (IC50 = 125 µg/mL) and relatively low toxicity towards the NIH/3T3 cell line (IC50 > 500 µg/mL).
合成了14种新的
噻唑烷脒衍
生物,并采用肉汤微量稀释法评估了它们的抗白念珠菌活性。在合成的化合物中,2-[2-((5-(4-
氯-2-
硝基苯基)
呋喃-2-基)亚甲基)
肼基]-4-(4-
氟苯基)
噻唑和2-[2-((5-(4-
氯-2-
硝基苯基)
呋喃-2-基)亚甲基)
肼基]-4-(4-
甲氧基苯基)
噻唑被发现是对Candida utilis最有效的抗真菌化合物,其最低抑菌浓度(MIC)值为250μg/mL,与
氟康唑(MIC = 2μg/mL)相比。此外,还评估了合成的化合物对MCF-7和NIH/3T3
细胞系的体外细胞毒性效应。结果表明,2-[2-((5-(4-
氯-2-
硝基苯基)
呋喃-2-基)亚甲基)
肼基]-4-(4-
氯苯基)
噻唑因其对MCF-7癌细胞的抑制作用(IC50 = 125μg/mL)和对NIH/3T3
细胞系的相对较低毒性(IC50 > 500μg/mL),被认为是针对MCF-7癌细胞最有前景的抗癌化合物。